InvestorsHub Logo
Followers 27
Posts 1096
Boards Moderated 0
Alias Born 01/07/2014

Re: None

Thursday, 11/19/2015 9:52:21 AM

Thursday, November 19, 2015 9:52:21 AM

Post# of 2676
Listened to the presentation yesterday.. CEO brings up many valid reason as to why ZYNE treatment will be effective.. Time line for data was laid out.. They are targeting a niche market and not in direct competition with GWPH.. Looking to broaden their patents after phase 1 data is complete.. They will have enough money to get thru all their phase 2 trails.. Overall, positive takeaways from this presentation.. Trading slightly below its IPO price of $14 shares seem significantly undervalued IMO !
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News